Disability

Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug AdministrationBreakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

NANJING, China, Sept. 5, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets…

10 months ago
George Medicines demonstrates potential of novel, low-dose, triple combination pill to transform management of hypertension in Hot Line Session at ESC Congress 2024George Medicines demonstrates potential of novel, low-dose, triple combination pill to transform management of hypertension in Hot Line Session at ESC Congress 2024

George Medicines demonstrates potential of novel, low-dose, triple combination pill to transform management of hypertension in Hot Line Session at ESC Congress 2024

George Medicines demonstrates potential of novel, low-dose, triple combination pill to transform management of hypertension in Hot Line Session at…

10 months ago
Report: Novel Alternative to QALYsReport: Novel Alternative to QALYs

Report: Novel Alternative to QALYs

Alliance for Aging Research has worked with Milliman to develop a methodology — Standard of Living Valuation — that benefits patients,…

10 months ago
Tennesseans With Intellectual and Developmental Disabilities Aren’t Getting Dental Treatment. What Needs to Change?Tennesseans With Intellectual and Developmental Disabilities Aren’t Getting Dental Treatment. What Needs to Change?

Tennesseans With Intellectual and Developmental Disabilities Aren’t Getting Dental Treatment. What Needs to Change?

AIDPH and Harmony Health assess oral health barriersRIVER FOREST, IL / ACCESSWIRE / August 27, 2024 / Tennesseans with intellectual…

10 months ago
CAMP4 Therapeutics Secures Rare Pediatric Disease Designation for CMP-CPS-001 for the Treatment of Urea Cycle DisordersCAMP4 Therapeutics Secures Rare Pediatric Disease Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders

CAMP4 Therapeutics Secures Rare Pediatric Disease Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders

CAMBRIDGE, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics, a clinical-stage biotechnology company developing a pipeline of RNA-based therapeutics…

10 months ago
Therma Bright Major Milestone: Portfolio Company Inretio’s Preva(R) Device Achieves 3rd Human Trial SuccessTherma Bright Major Milestone: Portfolio Company Inretio’s Preva(R) Device Achieves 3rd Human Trial Success

Therma Bright Major Milestone: Portfolio Company Inretio’s Preva(R) Device Achieves 3rd Human Trial Success

Game-Changing Innovation Poised to Transform Stroke and Blood Clot TreatmentTherma Bright's Strategic Investment Helps Medical Device Company Demonstrate Efficacy and…

10 months ago
Beyond Medals: The Toughest Discipline is Overcoming Daily Disability BarriersBeyond Medals: The Toughest Discipline is Overcoming Daily Disability Barriers

Beyond Medals: The Toughest Discipline is Overcoming Daily Disability Barriers

Ottobock Launches Paralympic Games Initiative: ‘The Unofficial Discipline'BURLINGTON, ON / ACCESSWIRE / August 26, 2024 / As the world gathers…

10 months ago
Lindus Health Announces the Completion of Two Clinical Trials for Woebot Health’s Digital Application for Depression and Anxiety SymptomsLindus Health Announces the Completion of Two Clinical Trials for Woebot Health’s Digital Application for Depression and Anxiety Symptoms

Lindus Health Announces the Completion of Two Clinical Trials for Woebot Health’s Digital Application for Depression and Anxiety Symptoms

NEW YORK, Aug. 22, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science…

11 months ago
Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutionsStryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions

Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions

Portage, Michigan, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a…

11 months ago